Publication:
Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)

Simple item page
dc.contributor.authorsOzkan, M.; Cicin, I.; Ozaslan, E.; Benekli, M.; Oksuzoglu, B.; Kocer, M.; Isikdogan, A.; Sevinc, A.; Karaoglu, A.; Dane, F.; Cubukcu, E.; Elkiran, E. T.; Aliustaoglu, M.
dc.date.accessioned2022-03-12T16:15:53Z
dc.date.accessioned2026-01-11T15:21:56Z
dc.date.available2022-03-12T16:15:53Z
dc.date.issued2015
dc.identifier.doi10.1016/S0959-8049(16)30707-9
dc.identifier.eissn1879-0852
dc.identifier.issn0959-8049
dc.identifier.urihttps://hdl.handle.net/11424/225668
dc.identifier.wosWOS:000361887401113
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofEUROPEAN JOURNAL OF CANCER
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleLow molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS245
oaire.citation.startPageS245
oaire.citation.titleEUROPEAN JOURNAL OF CANCER
oaire.citation.volume51

Files

Collections

Araştırma Çıktıları